Am I Really Ready to Cope with PD?
The Internet's most comprehensive resource for movement disorder information and the hub of movement disorder activities on the web. Web Site, the Internet's most comprehensive resource for movement disorder information and the hub of movement ... [... more]
We Move |
Symptoms/Findings
Many individuals with Wilson disease experience symptoms associated with damage to the nervous system. These symptoms usually become apparent during the second decade of life or, in some patients, during the third decade; however, such findings ... [... more]
We Move |
WE MOVE - Wilson Disease - Treatment
The goal of drug therapy in individuals with Wilson disease is to remove excess copper from the body and prevent ongoing copper accumulation and deposition. Therefore, drug therapy must be continued throughout life. Inadequate treatment or ... [... more]
We Move |
Symptoms/Findings/Clinical Course
In females with classic RS, the disease course tends to follow a relatively predictable pattern, although the age at onset and symptom severity may be somewhat variable. Less commonly, patients may meet some but not all the diagnostic criteria ... [... more]
We Move |
WE MOVE - Rett Syndrome - Treatment
The treatment of RS patients requires an integrated, multidisciplinary approach including symptomatic and supportive medical management; physical, occupational, and speech therapy; and special academic, social, vocational, and supportive ... [... more]
We Move |
Overview of Sydenham's Chorea
Sydenham's chorea is a neurologic movement disorder characterized by irregular, abrupt, relatively rapid involuntary movements (i.e., chorea) of muscles of the face, neck, trunk, and arms and legs (limbs). Sydenham's chorea is a neurologic ... [... more]
We Move |
WE MOVE - Tourette's Syndrome - Treatment
The goal of therapy in patients with TS is to reduce motor and vocal tics and alleviate associated behavioral problems, such as obsessive-compulsive behaviors, ADHD, and impulsivity. The goal of therapy in patients with TS is to reduce motor and ... [... more]
We Move |
Multiple System Atrophy
Multiple system atrophy (MSA) is a neurodegenerative disease marked by a combination of symptoms affecting movement, blood pressure, and other body functions; hence the label multiple system atrophy. The cause of MSA is unknown. Multiple System ... [... more]
We Move |
Diagnosis of Restless Legs Syndrome
Dopaminergic agents are often considered first-line therapies since they typically alleviate all major features associated with RLS including restlessness, abnormal sensations, involuntary movements, and associated sleep impairment. The diagnosis ... [... more]
We Move |
Causes/Genetics
Essential tremor is usually considered a slowly progressive, chronic condition. However, there may be periods when the symptoms remain unchanged and do not worsen. In addition, in many people, the disease may be relatively non-progressive and the ... [... more]
We Move |
WE MOVE - Parkinson's Disease - Diagnosis
Since there is no specific test or marker for PD, diagnosis is by a physician and depends on the presence of at least two of the three major signs: tremor at rest, rigidity, and bradykinesia, as well as the absence of a secondary cause. Since ... [... more]
We Move |
Parkinson's Disease
If you or someone you are close to has Parkinson's disease (PD), please read this section. You will find information about today's most effective treatment options for PD. Medical Editor: Richard Robinson, NASW; Joy B. Leffler, NASW, AMIA Medical ... [... more]
We Move |
